Advertisement

Re: What is the role of NeuroSAFE in robotic radical prostatectomy?

  • Eoin DinneenEmail author
  • A. Haider
  • J. Grierson
  • T. Briggs
  • R. Persad
  • N. Oakley
  • A. Freeman
  • G. Shaw
Letter to the Editor
  • 19 Downloads

Notes

Compliance with ethical standards

Conflict of interest

ED, AH, JG, TB, RP, NO, AF, and GS have no conflicts of interest.

References

  1. 1.
    Goonewardene SS, Cahill D (2019) What is the role of Neurosafe in robotic radical prostatectomy? J Robot Surg 13(1):187–188CrossRefGoogle Scholar
  2. 2.
    Beyer B, Schlomm T, Tennstedt P, Boehm K, Adam M, Schiffmann J et al (2014) A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy. Eur Urol 66(1):138–144CrossRefGoogle Scholar
  3. 3.
    Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U et al (2012) Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol 62(2):333–340CrossRefGoogle Scholar
  4. 4.
    Tewari AK, Srivastava A, Huang MW, Robinson BD, Shevchuk MM, Durand M et al (2011) Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP). BJU Int 108(6 Pt 2):984–992CrossRefGoogle Scholar
  5. 5.
    Mirmilstein G, Rai BP, Gbolahan O, Srirangam V, Narula A, Agarwal S et al (2018) The neurovascular structure-adjacent frozen-section examination (NeuroSAFE) approach to nerve sparing in robot-assisted laparoscopic radical prostatectomy in a British setting—a prospective observational comparative study. BJU Int 121(6):854–862CrossRefGoogle Scholar
  6. 6.
    Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J (2017) Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study. Lancet Oncol 18(11):1445–1453CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Surgery and Interventional ScienceUniversity College London, Charles Bell HouseLondonUK
  2. 2.Department of UrologyUniversity College London HospitalLondonUK
  3. 3.Department of HistopathologyUniversity College London HospitalLondonUK
  4. 4.Surgical and Interventional Trials UnitUniversity College LondonLondonUK
  5. 5.Department of UrologyNorth Bristol Hospitals TrustBristolUK
  6. 6.Department of UrologySheffield Teaching Hospitals NHS TrustSheffieldUK

Personalised recommendations